Relyea Zuckerberg Hanson LLC Buys 750 Shares of Procter & Gamble Company (The) $PG

Relyea Zuckerberg Hanson LLC increased its position in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 3.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,782 shares of the company’s stock after buying an additional 750 shares during the quarter. Relyea Zuckerberg Hanson LLC’s holdings in Procter & Gamble were worth $4,108,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Belpointe Asset Management LLC lifted its position in shares of Procter & Gamble by 25.6% in the 2nd quarter. Belpointe Asset Management LLC now owns 30,223 shares of the company’s stock worth $4,815,000 after acquiring an additional 6,153 shares during the period. Confluence Wealth Services Inc. increased its position in shares of Procter & Gamble by 0.3% during the second quarter. Confluence Wealth Services Inc. now owns 44,224 shares of the company’s stock valued at $7,046,000 after purchasing an additional 134 shares during the period. Gratus Wealth Advisors LLC raised its stake in shares of Procter & Gamble by 0.5% in the second quarter. Gratus Wealth Advisors LLC now owns 13,746 shares of the company’s stock valued at $2,190,000 after purchasing an additional 69 shares in the last quarter. Eads & Heald Wealth Management lifted its position in Procter & Gamble by 0.8% in the second quarter. Eads & Heald Wealth Management now owns 14,175 shares of the company’s stock worth $2,258,000 after purchasing an additional 114 shares during the period. Finally, Autumn Glory Partners LLC boosted its stake in Procter & Gamble by 34.6% during the second quarter. Autumn Glory Partners LLC now owns 9,852 shares of the company’s stock worth $1,570,000 after buying an additional 2,534 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

NYSE PG opened at $152.19 on Monday. Procter & Gamble Company has a 1-year low of $149.91 and a 1-year high of $180.43. The company has a 50 day moving average of $155.51 and a 200-day moving average of $159.95. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The firm has a market cap of $356.20 billion, a price-to-earnings ratio of 23.38, a PEG ratio of 4.02 and a beta of 0.36.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same period in the prior year, the company earned $1.40 EPS. Procter & Gamble’s revenue for the quarter was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble’s payout ratio is currently 64.82%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on PG. UBS Group set a $180.00 price objective on shares of Procter & Gamble and gave the company a “buy” rating in a research note on Wednesday, July 30th. Barclays dropped their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research report on Wednesday. Berenberg Bank lifted their price objective on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a report on Wednesday, September 17th. Evercore ISI reiterated an “in-line” rating and issued a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Finally, BNP Paribas restated an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average price target of $173.11.

Read Our Latest Stock Analysis on PG

Insider Buying and Selling at Procter & Gamble

In other news, CEO Gary A. Coombe sold 10,194 shares of the company’s stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the transaction, the chief executive officer directly owned 34,978 shares in the company, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Andre Schulten sold 11,638 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the sale, the chief financial officer directly owned 52,642 shares of the company’s stock, valued at approximately $8,279,007.34. This represents a 18.11% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock worth $18,918,012 over the last quarter. Corporate insiders own 0.20% of the company’s stock.

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.